Literature DB >> 21691912

[Total ankle arthroplasty for rheumatoid arthritis].

S Schill1, R Wetzel.   

Abstract

Modern second generation total ankle arthroplasty is now a serious alternative to ankle fusion in patients with rheumatoid arthritis after careful assessment of the indications. The midterm results with 10-year survival rates between 70% and 90% and the possible revision for implant exchange or arthrodesis are the reasons for the increasing importance of ankle arthroplasty. Patients with rheumatoid arthritis in particular with generally lower physical requirements can expect a pain-free function of the operated ankle for 8-10 years. In comparison to fusion ankle arthroplasty allows a significantly faster remobilization and reserves the correction capabilities of the ankle. Arthrodesis remains a valuable therapeutic alternative for severe bony destruction and instability as well as a possible fallback for failure of arthroplasty.

Entities:  

Mesh:

Year:  2011        PMID: 21691912     DOI: 10.1007/s00393-011-0777-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  36 in total

Review 1.  Biomechanics of and research challenges in uncemented total ankle replacement.

Authors:  Gladius Lewis
Journal:  Clin Orthop Relat Res       Date:  2004-07       Impact factor: 4.176

2.  [Ankle prostheses. Mid-term results after Thompson-Richards and STAR prostheses].

Authors:  S Schill; C Biehl; H Thabe
Journal:  Orthopade       Date:  1998-03       Impact factor: 1.087

3.  Gait analysis after successful mobile bearing total ankle replacement.

Authors:  H Cornelis Doets; Marienke van Middelkoop; Han Houdijk; Rob G H H Nelissen; H E J Dirkjan Veeger
Journal:  Foot Ankle Int       Date:  2007-03       Impact factor: 2.827

4.  The effect of accuracy of implantation on range of movement of the Scandinavian Total Ankle Replacement.

Authors:  Y Tochigi; M J Rudert; T D Brown; T E McIff; C L Saltzman
Journal:  J Bone Joint Surg Br       Date:  2005-05

5.  The HINTEGRA ankle: rationale and short-term results of 122 consecutive ankles.

Authors:  Beat Hintermann; Victor Valderrabano; Greta Dereymaeker; Walter Dick
Journal:  Clin Orthop Relat Res       Date:  2004-07       Impact factor: 4.176

6.  Kinematic changes after fusion and total replacement of the ankle: part 1: Range of motion.

Authors:  Victor Valderrabano; Beat Hintermann; Benno M Nigg; Darren Stefanyshyn; Pro Stergiou
Journal:  Foot Ankle Int       Date:  2003-12       Impact factor: 2.827

7.  Ankle arthrodesis: a long-term study.

Authors:  R V Abdo; S A Wasilewski
Journal:  Foot Ankle       Date:  1992 Jul-Aug

8.  Comparison of reoperation rates following ankle arthrodesis and total ankle arthroplasty.

Authors:  Nelson F SooHoo; David S Zingmond; Clifford Y Ko
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

Review 9.  History and evolution in total ankle arthroplasty.

Authors:  Nikolaos E Gougoulias; Anil Khanna; Nicola Maffulli
Journal:  Br Med Bull       Date:  2008-11-13       Impact factor: 4.291

10.  Total ankle joint replacement: a clinical follow up.

Authors:  N C Jensen; K Krøner
Journal:  Orthopedics       Date:  1992-02       Impact factor: 1.390

View more
  5 in total

1.  [Orthopedic rheumatology].

Authors:  S Rehart; M Henniger
Journal:  Orthopade       Date:  2012-07       Impact factor: 1.087

2.  [Endoprosthetic treatment of the ankle].

Authors:  J Götz; J Grifka; H R Springorum; S May; C Baier
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

3.  [Hindfoot deformities in adults. Conservative and surgical treatment].

Authors:  J Götz; J Grifka; C Baier
Journal:  Orthopade       Date:  2016-01       Impact factor: 1.087

Review 4.  [Surgery for inflammatory rheumatic joint destruction].

Authors:  S Rehart; M Henniger
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

Review 5.  [Rheumatism operations in a state of flux-"Foot"].

Authors:  C Baier; T Schwarz; J Schaumburger; F Leiß; J Grifka; G Maderbacher
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.